Investing

A collection of 650 posts

Paid-members only

Markets Featured

$IBRX: The FDA Said Yes 12 Weeks Early. The Russell Math Hits October 30.

ImmunityBio's ANKTIVA just won its papillary bladder cancer label almost three months ahead of its January PDUFA date. The stock barely moved. The share count, the cash clock, and an October 30 Russell index trigger explain why, and set the scenario zones.

Paid-members only

AI Featured

The Quantum Roll-Up Just Met the Bear Market

IonQ's up-to-$1.3 billion all-stock deal for Elisity is its third ten-figure acquisition in sixteen months — announced with its shares down nearly 60% from their peak. When a roll-up's currency collapses, the strategy becomes the story.

Infrastructure Featured

Cargo Thieves Don't Break Into Trucks Anymore. They Buy the Trucking Company.

Strategic cargo theft has turned U.S. freight into a fraud market: criminals buy real trucking companies for $22,000 and drive off with millions. Losses doubled to $304.6M last quarter — and Washington is finally moving.

Members only

Energy Featured

Uranium Says Boom. Nuclear Stocks Say Bust. Which Market Is Lying?

Uranium term prices hit a nominal record while Oklo, NuScale, and Centrus lost half their value. The divergence between the physical market and nuclear equities is the most important signal in commodities right now.

Paid-members only

Markets Featured

$VSTM: The 50% Response Rate Is Real. So Is the 31% Dilution.

Markets Featured

A Man Died on a Six Flags Coaster. No Federal Agency Has Jurisdiction.

One death on Goliath sent Six Flags shares sliding and reopened a 45-year-old statutory gap: no federal agency oversees America's fixed-site roller coasters — just as an activist pushes the company toward a sale.

Paid-members only

Finance Featured

$BMBL: Everyone Quoted the $1 Billion. Nobody Did the Per-Share Math

Bumble jumped 50% on reported $1 billion take-private talks with a Sequoia-backed vehicle. Whether that number is equity or enterprise value is a two-dollar-per-share question, and the market is pricing the cautious answer. The real share count, the debt math, and scenario-by-scenario price zones.

Members only

Finance Featured

'Resilience Is Not Safety': The IMF Just Mapped How This Market Breaks

The IMF's new Global Financial Stability Report names three catalysts for the next bout of market turmoil — an AI correction, a bond-yield spike, a cyber incident — and for the first time puts hard numbers on the leverage that would amplify them.

Finance Featured

Hospitals Buy the Drugs Cheap. Medicare Pays Full Price. January 1 Could End the Trade.

The 340B drug program hit $100 billion last year, and almost nobody outside health care can explain it. CMS just proposed paying hospitals 40 points less for drugs they buy at a discount — and this time it ran the survey the Supreme Court demanded.

Members only

Defence Featured

Why Korea's Defense Stocks Crashed the Year Everything Went Right

South Korea just flight-tested its first hypersonic glide vehicle, capping a year of record profits and export validations — while its defense stocks sit 44-63% below their spring peaks. The order book explains the gap, and what could refill it.

Paid-members only

Finance Featured

Crypto Spent a Decade Trying to Replace Wall Street's Plumbing. The Plumber Went On-Chain Instead.

DTCC — the utility that custodies $114 trillion — launches its tokenization service this month, with BlackRock, Goldman, and JPMorgan already trading tokenized assets in production. The winners aren't who the crypto market thinks.

Paid-members only

Finance Featured

$IREN: The Mystery Customer Finally Has a Name. The Stock Is Still Pricing Last Week's Bad News

Anthropic is reportedly the unnamed frontier lab behind one of IREN's biggest AI cloud contracts, days after a reliability critique knocked 16% off the stock. The balance-sheet clock, the November 5 date math, and scenario-by-scenario price zones.

Paid-members only

Markets Featured

Silver Hit $121 in January. The Shortage That Took It There Is Gone.

Deutsche Bank says the physical scarcity that drove silver's record spike has flipped to ample supply — and could become outright surplus by 2027. The repricing map for the metal and the miners, inside.

Members only

AI Featured

Nvidia Says It Never Bought Groq. A Delaware Lawsuit Says That's the Trick.

Two ex-Groq engineers are asking Delaware's Court of Chancery to rule that Nvidia's $20 billion license-and-hire deal was a merger in everything but name — the first shareholder test of the structure Big Tech uses to buy AI companies without buying them.

Members only

Finance Featured

American Express Missed $13 Billion in Suspected Dirty Money. The Stock Went Up.

The OCC fined Amex $350 million for a decade of AML failures — including insider-linked transactions. The market bought the stock anyway. What it saw in the fine print, and the look-back clause it's not pricing.

Paid-members only

Markets Featured

Top 10 Stocks We're Watching This Week — Opening Bell Edition

Banks open earnings season Tuesday, CPI lands Wednesday, and stocks sit at records while the 10-year holds 24-year highs. Ten names for the loudest week of the quarter, all tracked on the Watchlist from Friday's closes.

Paid-members only

Energy Featured

The Battery Recycling Gold Rush Just Went Bankrupt

America built an industry to break its dependence on Chinese battery metals. Then the metals got cheap — and the recyclers went bust. Who ends up owning the capacity, and how to position for the turn.

Members only

Transportation Featured

The Number That Sank Joby's Stock Came From a Courtroom, Not the FAA

A Tampa jury handed Joby a $116.9 million trade-secret verdict this week, driving the stock to a fresh 52-week low. The dollar figure isn't what decides the stock — the runway math behind it is.

Paid-members only

Markets Featured

$HUM: Humana Just Won Back the Star Rating It Sued Washington Over. The Market Repriced 2028 Overnight

Humana flipped 95% of its Medicare Advantage members into 4-star-plus plans for 2027, recovering the H5216 contract it sued CMS over and could not win back in court. The stock jumped ~14% premarket. We price the quality-bonus math, the Clover recalculation, and all three scenario zones.

Members only

Markets Featured

America Is Defunding Childcare. Wall Street Got Out First.

KinderCare priced its IPO at $24 two years ago today. It trades at $1.95. States are cutting subsidies, Washington rewrote the rules in May — and the market rendered its verdict on American childcare before the politicians noticed.

Paid-members only

Markets Featured

Novo Nordisk Invented the Obesity Trade. The Market Just Priced It for Losing.

Eli Lilly is worth more than $1 trillion. Novo Nordisk trades near its 52-week low with an FDA decision on CagriSema due before year-end. Inside the pill war that split the obesity trade in two — and the catalyst that could reset it.

Paid-members only

Markets Featured

$WOLF: The Pentagon Offered Wolfspeed $1.5 Billion. The Market Bought the Headline; the Filing Sells a Process

Wolfspeed surged 20%+ on a conditional $1.5B, 30-year Department of War loan commitment, one year out of Chapter 11. We price the conditions chain, the 7.5% warrant dilution, the Renesas overhang, and the three scenario zones from here.

Paid-members only

Space Economy Featured

Amazon Has 85 Days Left on Its Space Internet Promise. It Hasn't Launched a Satellite Since July.

Amazon says its Starlink rival starts commercial service this quarter. Its own mission log shows no launches since July 2, a waived FCC deadline behind it, and a spectrum penalty running to 2028 — the launch math, the Globalstar spread, and how to position.

Members only

Energy Featured

A Data Revision Crashed Lithium 22%. China's Biggest Mine Is Still Shut.

Lithium carbonate just hit its 2026 low — not on new supply, but on a stockpile restatement that doubled China's reported inventory overnight. Meanwhile the mine behind the whole rally lost its environmental approval again. One of these moves is temporary.

Paid-members only

Markets Featured

$PENG: Penguin Solutions Just Guided 40% Growth at a Mid-Teens Multiple. The Memory Cycle Is Both the Reason and the Risk

Penguin Solutions beat Q4 by a wide margin and guided FY2027 to roughly 40% growth, yet trades near 14x forward earnings, 29% below its July high. We price all three paths: the AI-infrastructure rerate, the cyclical grind, and the memory-cycle rollover.